Monthly Archives: January 2026

The Department of Health and Social Care (DHSC) has confirmed that the Serious Shortage Protocols (SSP) for Adipine® XL 30mg MR tablets (SSP084) and Adipine® XL 60mg MR tablets (SPP085) will expire at 23:59pm Friday 23rd January 2026. SSP 084 and SSP085 were originally set to expire on 6th February 2026 however, the expiry has been [...]

The post Expiry of SSP084 Adipine® XL 30mg MR tablets and SSP085 Adipine® XL 60mg MR tablets appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed the Serious Shortage Protocol (SSP086) for Latanoprost 50 micrograms/ml / Timolol 5 mg/ml (Fixapost®) eye drops 0.2 ml unit dose preservative‑free will expire at 23:59pm Friday 23rd January 2026  SSP086 was originally set to expire on 6th February 2026 but its expiry date has been brought forward because [...]

The post Expiry of SSP086 Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free appeared first on Community Pharmacy England.

Community Pharmacy England has launched a new patient-facing website to promote several of the key Advanced services that pharmacy teams provide and to direct patients to pharmacies in England that provide these services. The website (communitypharmacy.org.uk) provides information about the following three services: Pharmacy First Service (clinical pathways); Hypertension Case-Finding Service (publicly known as the [...]

The post New patient-facing website to promote NHS pharmacy clinical services appeared first on Community Pharmacy England.

Community Pharmacy England has published new guidance to help community pharmacy owners complete the Data Security and Protection Toolkit (DSPTK) 2026. The Toolkit is used to make a pharmacy’s information governance (IG) declaration and must be completed by Tuesday 30th June 2026. Community Pharmacy England has collaborated with the NHS DSPTK team to keep the workload associated [...]

The post Data Security & Protection Toolkit 2026: Community Pharmacy England guidance available appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Fingolimod Glenmark 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) Drug Alert Number: EL(26)A/02 Date issued: 21 January 2026 Glenmark Pharmaceuticals Europe Limited is recalling one batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test results that showed a delay in capsule [...]

The post MHRA Class 3 Medicines Recall: Fingolimod Glenmark 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) appeared first on Community Pharmacy England.